MOUNTAIN VIEW, Calif., May 9, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, today announced that Chief Executive Officer, Anja Krammer, will present an updated corporate overview at the JMP...
News Ticker
- [ June 8, 2023 ] Sr. Manager, Data Scientist – Thermo Fisher Scientific – South San Francisco, CA San Francisco Biotech Jobs
- [ June 8, 2023 ] BehaVR Appoints Former Pear Therapeutics, TytoCare and AVIA Executives to Senior Leadership Team News
- [ June 8, 2023 ] Carta Healthcare Secures $25 Million in Series B Funding with Additional Investments from Memorial Hermann Health System and UnityPoint Health News
- [ June 8, 2023 ] Activate Welcomes a Record 46 New Activate Fellows Whose Innovations Can Decarbonize Industries and Build a Cleaner, Safer Society News
- [ June 8, 2023 ] apree health Launches a New Comprehensive Navigation and Clinical Advocacy Solution News
Copyright © 2023 Biotech Networks, LLC
